Bone Therapeutics Provides Business Update for the Third Quarter of 2015 Read more about Bone Therapeutics Provides Business Update for the Third Quarter of 2015
Bone Therapeutics Awarded EUR 3 million in Funding to Support New Research Projects Read more about Bone Therapeutics Awarded EUR 3 million in Funding to Support New Research Projects
ALLOB® Delayed-Union Program Awarded at Cells Orthopedics Conference Read more about ALLOB® Delayed-Union Program Awarded at Cells Orthopedics Conference
Bone Therapeutics completes recruitment of the first half of patients in ALLOB® Phase IIA spinal fusion trial Read more about Bone Therapeutics completes recruitment of the first half of patients in ALLOB® Phase IIA spinal fusion trial
Bone Therapeutics announces its financial calendar for 2016 Read more about Bone Therapeutics announces its financial calendar for 2016
Bone Therapeutics Granted an Additional EUR 2 Million in Non-Dilutive Funding by the Walloon Region Read more about Bone Therapeutics Granted an Additional EUR 2 Million in Non-Dilutive Funding by the Walloon Region
Bone Therapeutics to participate in key investor and partnering conferences in the first half of 2016 Read more about Bone Therapeutics to participate in key investor and partnering conferences in the first half of 2016
Bone Therapeutics expands its delayed-union program with ALLOB® into multiple fractures Read more about Bone Therapeutics expands its delayed-union program with ALLOB® into multiple fractures
Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2016 Read more about Bone Therapeutics réaffirme son éligibilité au PEA-PME pour 2016
Bone Therapeutics extends Kasios collaboration Read more about Bone Therapeutics extends Kasios collaboration